Companies: 10,795·Total market cap: $144.5T
Plus Therapeutics, Inc.

Plus Therapeutics, Inc.

PSTVNASDAQHealthcare● Active
$5.53
+$0.12(+2.22%)
Market Cap$13380410
P/E Ratio
52W High$23.5
52W Low$2.9
Overview

Plus Therapeutics, Inc. (PSTV) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PSTV · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-417.08pstv eps ttm · pstv earnings per shareEarnings history
PE Ratio (TTM)pstv pe ratio ttm · pstv price to earningsPE Ratio deep dive
Revenue (TTM)$5.2Mpstv revenue ttm · pstv annual revenueFull revenue history
Dividend YieldNo Dividenddoes pstv pay dividends · pstv dividend yieldDividend history
Shares Outstanding3.1Mpstv shares outstanding · pstv floatShares outstanding history
Next EarningsAug 13, 2026Est.pstv earnings date · pstv next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$5.2M▼ 10.49% YoY
202320242025
plus therapeutics, inc. revenue · pstv revenue 2025
FY 2025Net Income-$22.4M▼ 72.49% YoY
202320242025
plus therapeutics, inc. net income · pstv profit 2025
FY 2025EPS$-7.19▲ +85.25% YoY
202320242025
pstv eps · plus therapeutics, inc. earnings per share 2025
TTM:Revenue: $5.2MNet Income: -$11.9MEPS: $-417.08View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis pstv a buy · pstv analyst rating
Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$25.00Low
$5.53Current
$25.00Avg Target352.08% upside
$25.00High
pstv price target · pstv 12 month forecast

Total: 4 · Buy rate: 75.0%

The PSTV analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $25.00, representing +352.08% upside from the current price of $5.53.

Stock Performance

Full History
1D+2.22%
1W+2.22%
1M-9.64%
3M-25.07%
YTD-56.83%
1Y-36.51%
5Y-99.47%

About Plus Therapeutics, Inc.

CEOMarc H. Hedrick
IPO DateJul 11, 2001
Employees21
CountryUS

Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and indiv…

what is plus therapeutics, inc. · pstv stock overview · plus therapeutics, inc. company profile · who is plus therapeutics, inc. ceo · pstv NASDAQ · plus therapeutics, inc. headquarters · plus therapeutics, inc. business segments

About Stock Overview & Key Data

Plus Therapeutics, Inc. (PSTV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 11, 2001. As of the latest trading session, PSTV stock price is $5.53, with a market capitalization of $13.4M. The stock has returned -36.51% over the past 12 months and -56.83% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Plus Therapeutics, Inc. stock is Buy, with an average 12-month price target of $25.00. In fiscal year 2025, Plus Therapeutics, Inc. reported revenue of $5.2M and net income of -$22.4M. For detailed data — including Plus Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Plus Therapeutics, Inc. (PSTV) stock price is $5.53. The stock is traded on NASDAQ under the ticker symbol PSTV. The 52-week range is $2.90 – $23.50.

PSTV stock pricePSTV quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice